GILEAD SCIENCES, INC. — Director's Dealing 2019

Feb 8, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2019-02-06

Reporting Person: Hamill Laura (EVP, Worldwide Commercial Ops)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-06	Non-qualified Stock Option (Right to Buy)	$68.75	A	63100	Acquired	2029-02-06	Common Stock (63100)	Direct
2019-02-06	Restricted Stock Unit	$	A	13640	Acquired		Common Stock (13640)	Direct

Footnotes

F1: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

F2: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3: The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.